Goldman Sachs Downgrades Impax Laboratories (IPXL) to Sell
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Rating Summary:
8 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
8 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Goldman Sachs downgraded Impax Laboratories (NASDAQ: IPXL) to Sell with a price target of $21.00.
The firm cited the absence of near-term catalysts to drive confidence and visibility, while risks persist, and below-consensus EPS estimates.
For more ratings news on Impax Laboratories click here and for the rating history of Impax Laboratories click here.
Shares of Impax Laboratories closed at $20.91 yesterday.
The firm cited the absence of near-term catalysts to drive confidence and visibility, while risks persist, and below-consensus EPS estimates.
For more ratings news on Impax Laboratories click here and for the rating history of Impax Laboratories click here.
Shares of Impax Laboratories closed at $20.91 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
- H.C. Wainwright Downgrades EyePoint Inc. (EYPT) to Neutral
- JPMorgan Downgrades East Money Information Co Ltd (300059:CH) to Neutral
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
